BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Whatman Inc. (WHM.L) to Distribute GenVault Corporation DNA Recovery Kits in North America


5/29/2008 10:38:21 AM

CARLSBAD, Calif., May 29 /PRNewswire/ -- GenVault Corporation, the leader in dry-state, room temperature biosample management solutions announced on May 29, 2008 that Whatman, Now part of GE Healthcare, will become a non-exclusive distributor of GenVault's GenSolve DNA recovery kits in North America.

The GenSolve DNA recovery kit enables FTA(R)1 card users to recovery high quality DNA from their archived samples with a simple, user-friendly and reliable procedure. The DNA that is recovered is double-stranded and compatible with a multitude of downstream genetic assays such as genotyping and PCR. GenSolve expands the utility of existing FTA(R) cards by uniquely delivering DNA in quantities and of a quality suitable for even the most challenging genetic analysis technologies.

"This distribution agreement allows Whatman to offer a unique method of extracting DNA from FTA Cards adding value to the FTA product line," states Richard Dool, Senior Vice President, North America. "And it enables our existing FTA customers to extend the number of tests they can run with their archived samples."

"GenVault is pleased to further our long-term relationship with Whatman. GenSolve is an enabling product that will allow users everywhere to extend the utility of samples stored in the dry-state," said David Wellis, Ph.D., Chief Executive Officer of GenVault.

About Whatman, Now Part of GE Healthcare

Whatman is a global leader in separations technology. FTA Technology offers solutions for biological sample collection and dry storage of analysis of nucleic acids at room temperature. With FTA Technology Whatman addresses critical needs of customers in forensics DNA data banking as well as in DNA sample collection for biomedical and pharmaceutical research. FTA Technology is a market leading product for DNA archiving for "look back" studies and for genetic analysis. For more information on FTA Technology from Whatman please visit www.whatman.com/fta.

About GE Healthcare

GE is Imagination at Work -- a diversified technology, media and financial services company focused on solving some of the world's toughest problems. With products and services ranging from aircraft engines, power generation, water processing and security technology to medical imaging, business and consumer financing, media content and advanced materials, GE serves customers in more than 100 countries and employs more than 300,000 people worldwide. For more information, visit the company's website at http://www.ge.com.

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

CONTACT: Whatman, Part of GE Healthcare, Shari States, Marketing
Communications Group Manager, Shari.States@whatman.com; GenVault
Corporation, Kerri McWeeny, Director of Marketing, kmcweeny@genvault.com

Web site: http://www.genvault.com//



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES